Black Diamond Therapeutics Announces Financial Results and Strategic Updates for Q1 2025
May 12, 2025 - 22:08
In a recent corporate update, Black Diamond Therapeutics revealed significant advancements in its clinical trials and financial standing for the first quarter of 2025. The company is on track to present clinical data from its Phase 2 trial of BDTX-1535, targeting first-line patients with non-classical EGFR mutations in non-small cell lung cancer (NSCLC), with results expected in the fourth quarter of 2025.
Additionally, the company has initiated an expansion of its investigator-sponsored Phase 0/1 trial, focusing on newly diagnosed glioblastoma patients with EGFR alterations. This expansion commenced in the first quarter of 2025, reflecting the company’s commitment to exploring innovative treatment options for challenging cancers.
Financially, Black Diamond Therapeutics reported cash, cash equivalents, and investments totaling $152.4 million as of March 31, 2025. This financial position is anticipated to adequately support the company’s operations through to the fourth quarter of 2027, ensuring continued progress in its clinical and research endeavors.
MORE NEWS
August 21, 2026 - 00:02
Broadcom Seeks More Than $60 Billion in Latest AI Debt DealBroadcom Inc. is negotiating with a consortium of lenders to secure upwards of $60 billion in new financing, a move aimed at bankrolling a major expansion of its artificial intelligence chip...
August 20, 2026 - 04:03
JPMorganChase to Present at the Barclays Global Financial Services ConferenceNEW YORK, August 19, 2026 - Doug Petno, who serves as Co-President of JPMorganChase and leads the firm`s Commercial & Investment Bank, is scheduled to appear at the Barclays Global Financial...
August 19, 2026 - 00:42
Sabalenka’s Coach Recalls Financial Sacrifices on Road to $50M CareerAryna Sabalenka has now banked more than fifty million dollars in career prize money, but the journey to that figure was far from glamorous. Her coach, Anton Dubrov, recently looked back on the...
August 18, 2026 - 04:03
Bending Spoons' Playbook: Buy Low—and HoldMost tech acquirers these days are looking for a quick flip. They buy a struggling app, cut costs, squeeze out whatever revenue they can, and then sell the shell to the next buyer within a year or...